Designated Substances Detected In 188 Products In MHLW Unauthorized Drug Purchase Survey
This article was originally published in PharmAsia News
Of the 313 pharmaceutical products purchased in MHLW’s unapproved or unauthorized pharmaceuticals purchase survey investigating the distribution of health foods and drugs containing illegal substances, designated substances were detected in 188 products.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.